Viravaxx

With new appointment, Viravaxx aims to step up a gear

Vienna, Jan 11, 2021. Austrian antiviral vaccine and immunodiagnostics specialist Viravaxx has appointed Helmut Brunar, former CEO and chairman at Axentis Pharma, as chief executive officer. Dr Brunar has expertise in vaccines, cell therapies and diagnostic products, having managed supply chain activities at Johnson & Johnson’s (NYSE: JNJ) COVID-19 vaccine program. At Axentis, he built a | read more »

Vienna, Jan 11, 2021. Austrian antiviral vaccine and immunodiagnostics specialist Viravaxx has appointed Helmut Brunar, former CEO and chairman at Axentis Pharma, as chief executive officer.

Dr Brunar has expertise in vaccines, cell therapies and diagnostic products, having managed supply chain activities at Johnson & Johnson’s (NYSE: JNJ) COVID-19 vaccine program. At Axentis, he built a team to develop respiratory drug candidate AX-TOBRA. Viravaxx focuses its activities on hard-to-treat viral infections such as respiratory syncytial virus and rhinovirus.

The company’s lead candidate is the clinical-stage hepatitis B therapy VVX001, for therapeutic and prophylactic vaccination, which is currently in Phase II trials.

Coronavirus vaccine candidate

Viravaxx is seeking to expedite development of vaccines against COVID-19 and other infectious diseases, facilitated by microarray-based a for whole-proteome analysis and vaccine design platforms.

The company said that recent progress with its SARS-CoV-2 Interaction Assay has created a turning point, and the new appointment is aime pushing the program forward.

A collaboration with Rudolf Valenta’s research group at the Medical University of Vienna is seeking to exploit technology to convert non- immunogenic epitopes of surface proteins into potent immunogens.

Viravaxx believes that the cooperation with the Valenta labs puts it in a strong position to strengthen its partnerships with big pharma and biotech.

Source: http://prd.at/en/newsroom-clients/immunodiagnostics-and-vaccine-development-at-viravaxx-ag-gain-momentum/